Febuxostat AB 80 mg film-coat. tabl.
Nazione: Belgio
Lingua: inglese
Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Invia richiesta.
Principio attivo:
Febuxostat 80 mg
Commercializzato da:
Aurobindo SA-NV
Codice ATC:
M04AA03
INN (Nome Internazionale):
Febuxostat
Dosaggio:
80 mg
Forma farmaceutica:
Film-coated tablet
Composizione:
Febuxostat 80 mg
Via di somministrazione:
Oral use
Area terapeutica:
Febuxostat
Dettagli prodotto:
CTI code: 538222-09 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-08 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-05 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-06 - Pack size: 84 - Commercialisation status: YES - FMD code: 08716049031968 - CNK code: 3911112 - Delivery mode: Medical prescription; CTI code: 538222-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-14 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-04 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-12 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-13 - Pack size: 84 - Commercialisation status: YES - FMD code: 08716049031968 - CNK code: 3911112 - Delivery mode: Medical prescription; CTI code: 538222-10 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 538222-11 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription
Stato dell'autorizzazione:
Commercialised: Yes
Data dell'autorizzazione:
2019-01-22
